Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy

被引:1
作者
Isakson, Pauline [1 ]
Pardi, Cecilia [1 ]
机构
[1] Sahlgrens Univ Hosp, Clin Immunol & Transfus Med, Gothenburg, Sweden
关键词
cffDNA; non-invasive fetal RHDgenotyping; hemolytic disease ofthe newborn; CELL-FREE DNA; MATERNAL PLASMA; HEMOLYTIC-DISEASE; WOMEN; PROGRAM; FETUS;
D O I
10.2450/2023.0267-22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - RhD immunization is still the major cause of hemolytic disease of the fetus and newborn. Fetal RHD genotyping during pregnancy followed by tailored anti -D prophylaxis for pregnant RhD-negative women carrying an RHD -positive fetus to prevent RhD immunization is a well -established practice in many countries. This study aimed to validate a platform for high -throughput, non-invasive, single-exon, fetal RHD genotyping consisting of automated DNA extraction and PCR set-up, and a novel system for electronic data transfer to the real-time PCR instrument. We also investigated the effect of storage conditions of fresh or frozen samples on the outcome of the assay. Materials and methods - Blood samples from 261 RhD-negative pregnant women collected in Gothenburg, Sweden, between November 2018 and April 2020 during gestation week 10-14 were either tested as fresh after storage for 0-7 days at room temperature or as thawed plasma samples previously separated and stored for up to 13 months at -80 degrees C. Extraction of cell -free fetal DNA and PCR set-up were performed in a closed automated system. Fetal RHD genotyping was determined by real-time PCR amplification of the RHD gene exon 4. Results - The outcome of RHD genotyping was compared with either the results obtained with serological RhD typing of newborns or with the results of RHD genotyping performed by other laboratories. No difference was observed in genotyping results when using fresh or frozen plasma during short- and long-term storage, revealing high stability of cell -free fetal DNA. The assay has shown high sensitivity (99.37%), specificity (100%), and accuracy (99.62%). Discussion - These data confirm that the proposed platform for non-invasive, single-exon, RHD genotyping early in pregnancy is accurate and robust. Importantly, we demonstrated the stability of cell -free fetal DNA in fresh and frozen samples after short- and long-term storage.
引用
收藏
页码:472 / 478
页数:108
相关论文
共 24 条
[1]   RhD hemolytic disease of the newborn [J].
Bowman, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (24) :1775-1777
[2]   Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women [J].
Clausen, FB ;
Krog, GR ;
Rieneck, K ;
Nielsen, LK ;
Lundquist, R ;
Finning, K ;
Dickmeiss, E ;
Hedegaard, M ;
Dziegiel, MH .
PRENATAL DIAGNOSIS, 2005, 25 (11) :1040-1044
[3]   Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis [J].
Clausen, Frederik Banchpdf ;
Christiansen, Mette ;
Steffensen, Rudi ;
Jorgensen, Steffen ;
Nielsen, Christian ;
Jakobsen, Marianne Antonius ;
Madsen, Rikke Dyhrberg ;
Jensen, Karina ;
Krog, Grethe Risum ;
Rieneck, Klaus ;
Sprogoe, Ulrik ;
Homburg, Keld Mikkelsen ;
Grunnet, Niels ;
Dziegiel, Morten Hanefeld .
TRANSFUSION, 2012, 52 (04) :752-758
[4]   Variants of RhD - current testing and clinical consequences [J].
Daniels, Geoff .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (04) :461-470
[5]   Haemolytic disease of the fetus and newborn [J].
de Haas, M. ;
Thurik, F. F. ;
Koelewijn, J. M. ;
van der Schoot, C. E. .
VOX SANGUINIS, 2015, 109 (02) :99-113
[6]   Anti-D prophylaxis: past, present and future [J].
de Haas, M. ;
Finning, K. ;
Massey, E. ;
Roberts, D. J. .
TRANSFUSION MEDICINE, 2014, 24 (01) :1-7
[7]   Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands [J].
de Haas, Masja ;
Thurik, Florentine F. ;
van der Ploeg, Catharina P. B. ;
Veldhuisen, Barbera ;
Hirschberg, Hoang ;
Soussan, Aicha Ait ;
Woortmeijer, Heleen ;
Abbink, Frithjofna ;
Page-Christiaens, Godelieve C. M. L. ;
Scheffer, Peter G. ;
van der Schoot, C. Ellen .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
[8]   Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn [J].
Dziegiel, Morten Hanefeld ;
Krog, Grethe Risum ;
Hansen, Anne Todsen ;
Olsen, Marianne ;
Lausen, Birgitte ;
Norgaard, Lone Nikoline ;
Bergholt, Thomas ;
Rieneck, Klaus ;
Clausen, Frederik Banch .
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (05) :306-315
[9]   Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women:: prospective feasibility study [J].
Finning, Kirstin ;
Martin, Pete ;
Summers, Joanna ;
Massey, Edwin ;
Poole, Geoff ;
Daniels, Geoff .
BRITISH MEDICAL JOURNAL, 2008, 336 (7648) :816-818
[10]   Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland [J].
Haimila, Katri ;
Sulin, Kati ;
Kuosmanen, Malla ;
Sareneva, Inna ;
Korhonen, Anu ;
Natunen, Suvi ;
Tuimala, Jarno ;
Sainio, Susanna .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2017, 96 (10) :1228-1233